Mechanism of Staphylococcus aureus exotoxin A inhibition of Ig production by human B cells

A B Moseley1, D P Huston

  • 1Department of Medicine, Baylor College of Medicine, Houston, TX.

Insights

Staphylococcal enterotoxins like SEA can either stimulate B cell proliferation and Ig production or suppress it, depending on T cell presence and activation. This T cell-dependent suppression of immunoglobulin production requires T cell proliferation.

Area of Science:

  • Immunology
  • Microbial Pathogenesis
  • Molecular Biology

Background:

  • Staphylococcus enterotoxins (SEs) and toxic shock syndrome toxin 1 (TSST-1) are staphylococcal exoproteins that bind MHC class II molecules.
  • These toxins potently stimulate T cell proliferation and monocyte cytokine secretion (IL-1, TNF-alpha).
  • SEs are known to inhibit immunoglobulin (Ig) production by peripheral blood mononuclear cells (PBMCs).

Purpose of the Study:

  • To investigate the direct effects of Staphylococcus enterotoxin A (SEA) on human B cell proliferation and Ig production.
  • To determine if SEA-induced inhibition of Ig production by PBMCs is T cell-dependent.
  • To elucidate the role of T cell proliferation in SEA-mediated effects on B cells.

Main Methods:

  • Cultured highly purified human B cells with SEA, Staphylococcus aureus Cowan strain I (SAC), and/or recombinant IL-2 (rIL-2).
  • Utilized anti-DR mAb L243 to block MHC class II molecules on B cells.
  • Examined SEA's effect on Ig production in PBMC cultures with or without T cells, employing pretreated (irradiated or mitomycin C) and untreated T cells.

Main Results:

  • SEA binding to MHC class II on B cells did not affect their proliferation or Ig production in response to SAC +/- rIL-2.
  • SEA's capacity to inhibit Ig production by PBMCs was T cell-dependent, requiring T cell proliferation.
  • SEA could either stimulate B cell proliferation and Ig production (with T cell help) or induce T cell-mediated suppression of Ig production.

Conclusions:

  • SEA does not directly affect human B cell proliferation or Ig production.
  • T cell activation and proliferation are critical for both SEA-induced B cell stimulation and suppression of Ig production.
  • SEA exhibits dual roles in modulating B cell immunity, contingent on T cell involvement and activation status.

Related Concept Videos

Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...